Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Swiss Medical Weekly|September 17, 2015
Data mining The Cancer Genome Atlas in the era of precision cancer medicinePhil F Cheng, Reinhard Dummer, Mitchell P LevesqueFrontiers in Oncology|June 14, 2018
Melanoma Immunotherapy: Next-Generation BiomarkersSabrina A Hogan, Mitchell P Levesque, Phil F ChengCurrent Opinion in Oncology|January 8, 2016
Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanomaVerena Paulitschke, Ossia Eichhoff, Phil F Cheng, et al.Cancer Metastasis Reviews|March 22, 2017
Metastatic melanoma moves on: translational science in the era of personalized medicineMitchell P Levesque, Phil F Cheng, Marieke I G Raaijmakers, et al.European Journal of Dermatology : EJD|January 18, 2021
Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysisSabine V Ludwig, Phil F Cheng, Joanna Mangana, et al.Oncotarget|December 29, 2022
Impact of Covid-19 on the management of patients with metastatic melanomaMichèle Welti, Phil F Cheng, Joanna Mangana, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCLSima Rozati, Phil F Cheng, Daniel S Widmer, et al.Journal for Immunotherapy of Cancer|July 5, 2024
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroidsElias Burri, Joanna Mangana, Phil F Cheng, et al.Frontiers in Cell and Developmental Biology|June 13, 2022
Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis FormationUlf Guendisch, Benjamin Loos, Phil F Cheng, et al.Pageof 7